XML 35 R23.htm IDEA: XBRL DOCUMENT v3.20.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
9 Months Ended
Sep. 30, 2020
Accounting Policies [Abstract]  
Schedule of Cash and Cash Equivalents
The reconciliation of cash and cash equivalents and restricted cash and cash equivalents to amounts presented in the consolidated statements of cash flows are as follows:
As of
September 30, 2020December 31, 2019
Cash and cash equivalents$907,530 $85,688 
Restricted cash and cash equivalents – current
10,952 — 
Restricted cash and cash equivalents – non-current4,000 4,144 
Cash, cash equivalents and restricted cash and cash equivalents$922,482 $89,832 
Restrictions on Cash and Cash Equivalents
The reconciliation of cash and cash equivalents and restricted cash and cash equivalents to amounts presented in the consolidated statements of cash flows are as follows:
As of
September 30, 2020December 31, 2019
Cash and cash equivalents$907,530 $85,688 
Restricted cash and cash equivalents – current
10,952 — 
Restricted cash and cash equivalents – non-current4,000 4,144 
Cash, cash equivalents and restricted cash and cash equivalents$922,482 $89,832 
Fair Value, Assets Measured on Recurring and Nonrecurring Basis The carrying value and fair value of the Company’s financial instruments are as follows:
As of September 30, 2020
Level 1Level 2Level 3Total
Assets
Cash equivalents – money market$662,275 $— $— $662,275 
Restricted cash equivalents – money market$4,100 $— $— $4,100 
As of December 31, 2019
Level 1Level 2Level 3Total
Assets
Cash equivalents – money market$73,005 — — $73,005 
Restricted cash equivalents – money market4,144 — — 4,144 
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation The change in fair value of the Forward Contract Liability was as follows:
Balance as of December 31, 2019
— 
Change in fair value1,324 
Settlement of forward contract liability$(1,324)
Balance as of September 30, 2020
$— 
Fair Value Measurement Inputs and Valuation Techniques The following reflects the significant quantitative inputs used:
As of
April 10, 2020December 31, 2019
Estimated future value of Series D redeemable convertible preferred stock$10.00 $9.74 
Discount rate— %1.56 %
Time to liquidity (years)00.3